Telomere shortening in patients on long-term hemodialysis

被引:1
|
作者
Yucheng Wang
Siyu Chen
Shi Feng
Cuili Wang
Hong Jiang
Song Rong
Haller Hermann
Jianghua Chen
Ping Zhang
机构
[1] Kidney Disease Center
[2] The First Affiliated Hospital
[3] College of Medicine
[4] Zhejiang University
[5] Hangzhou
[6] Zhejiang 310003
[7] ChinaKidney Disease Center
[8] ChinaClinic for Kidney and Hypertension Diseases
[9] Hannover Medical School
[10] Lower Saxony
[11] GermanyClinic for Kidney and Hypertension Diseases
[12] GermanyKidney Disease Center
关键词
Telomere length; Hemodialysis; Chronic kidney disease; Cardiovascular disease; Hemoglobin;
D O I
暂无
中图分类号
R692.5 [肾功能衰竭];
学科分类号
1002 ; 100210 ;
摘要
Background: Leukocyte telomere length shortening is a characteristic of premature senescence, a process that can be accelerated by oxidative stress. In general, patients with end-stage renal disease undergoing regular hemodialysis (HD) are repeatedly exposed to oxidative stress. Patients undergoing HD tend to have cardiovascular diseases associated with oxidative stress and inflammation. Therefore, we assumed that telomere length is associated with HD vintage and the degree of vascular calcification.Methods: A total of 144 patients undergoing regular HD before kidney transplantation and 62 patients on hemodialysis, but not undergoing kidney transplantation, were enrolled. We measured common laboratory values, such as calcium, phosphate, and hemoglobin levels, and assessed the degree of vascular calcification in the patients. The leukocyte telomere length was measured using reverse transcription polymerase chain reaction, and Spearman correlation was used for correlation analysis.Results: The leukocyte telomere length was negatively associated with age (rho = -0.306,P <0.01); it was shorter in middle-aged patients than in young patients (13.48 ± 4.80 vs. 15.86 ± 4.51,P < 0.01). The telomere length was significantly different among patients aged 52-74 years in groups with different HD vintages. Additionally, the telomere length was positively associated with serum hemoglobin (Hb) levels in all patients (rho = 0.290,P < 0.01). There was a significant difference among patients divided into three groups according to the degree of anemia (17.09 ± 5.64 vs. 14.40 ± 4.07 vs. 13.99 ± 3.95,P < 0.01). Further, a significant difference was observed in the telomere length among patients with different degrees of vascular calcification (16.79 ± 4.91 vs. 13.61 ± 2.82 vs. 14.62 ± 3.63 vs. 10.71 ± 3.74,P < 0.01). The telomere length was shorter in the patients on hemodialysis who did not receive a kidney transplant than in the surgical patients (8.12 ± 1.83 vs. 14.33 ± 4.63,P < 0.01).Conclusion: This study demonstrated that the telomere length was significantly correlated with HD vintage in patients of a certain age group. The telomere length was shorter in patients on hemodialysis who matched for age and dialysis vintage with kidney transplant patients. It was also associated with vascular calcification and serum Hb levels in all patients undergoing HD.
引用
收藏
页码:266 / 275
页数:10
相关论文
共 50 条
  • [31] Independent and Combined Effects of Telomere Shortening and mtDNA4977 Deletion on Long-term Outcomes of Patients with Coronary Artery Disease
    Vecoli, Cecilia
    Borghini, Andrea
    Pulignani, Silvia
    Mercuri, Antonella
    Turchi, Stefano
    Picano, Eugenio
    Andreassi, Maria Grazia
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (21)
  • [32] MEGALOBLASTIC HEMATOPOIESIS IN UREMIA AND IN PATIENTS ON LONG-TERM HEMODIALYSIS
    HAMPERS, CL
    STREIFF, R
    NATHAN, DG
    SNYDER, D
    MERRILL, JP
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1967, 276 (10): : 551 - &
  • [33] Changes in QTc interval in long-term hemodialysis patients
    Matsumoto, Yoshihiro
    Mori, Yasuo
    Kageyama, Shinji
    Arihara, Kazuo
    Sato, Hidemaro
    Nagata, Kijun
    Shimada, Yasushi
    Nojima, Yohichi
    Iguchi, Koichiro
    Sugiyama, Toshikazu
    [J]. PLOS ONE, 2019, 14 (01):
  • [34] Cancer surveillance in patients receiving long-term hemodialysis
    Palestini, M
    Lucandri, G
    Sterpetti, A
    Izzo, L
    Orefici, F
    Cavallaro, A
    [J]. ANTICANCER RESEARCH, 2002, 22 (2B) : 1305 - 1310
  • [35] INTRAVENOUS AZLOCILLIN KINETICS IN PATIENTS ON LONG-TERM HEMODIALYSIS
    ALETTA, JM
    FRANCKE, EF
    NEU, HC
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 27 (04) : 563 - 566
  • [36] ABDOMINAL ANGINA IN PATIENTS RECEIVING LONG-TERM HEMODIALYSIS
    VAZ, AJ
    [J]. SOUTHERN MEDICAL JOURNAL, 1981, 74 (02) : 175 - 177
  • [37] ANTIBODIES TO DNA IN PATIENTS UNDERGOING LONG-TERM HEMODIALYSIS
    DASGUPTA, MK
    DAVIS, P
    HIGGINS, MR
    DOSSETOR, JB
    [J]. CLINICAL NEPHROLOGY, 1980, 14 (06) : 288 - 293
  • [38] ANTIBODIES TO DNA IN PATIENTS UNDERGOING LONG-TERM HEMODIALYSIS
    DASGUPTA, MK
    DAVIS, P
    HIGGINS, MR
    DOSSETOR, JB
    [J]. CLINICAL RESEARCH, 1980, 28 (03): : A695 - A695
  • [39] Pulmonary function in uremic patients on long-term hemodialysis
    Karacan, Ö
    Tutal, E
    Uyar, M
    Eyüboglu, FÖ
    Sezer, S
    Özdemir, FN
    [J]. RENAL FAILURE, 2004, 26 (03) : 273 - 278
  • [40] DERMATOLOGICAL FINDINGS IN PATIENTS UNDERGOING LONG-TERM HEMODIALYSIS
    LUBACH, D
    [J]. HAUTARZT, 1980, 31 (02): : 82 - 85